BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 31082387)

  • 1. Group 2 Innate Lymphoid Cells in Airway Diseases.
    Kato A
    Chest; 2019 Jul; 156(1):141-149. PubMed ID: 31082387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cells are necessary for ILC2 activation in house dust mite-induced allergic airway inflammation in mice.
    Li BW; de Bruijn MJ; Tindemans I; Lukkes M; KleinJan A; Hoogsteden HC; Hendriks RW
    Eur J Immunol; 2016 Jun; 46(6):1392-403. PubMed ID: 27062360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms.
    Kabata H; Moro K; Koyasu S
    Immunol Rev; 2018 Nov; 286(1):37-52. PubMed ID: 30294963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate Lymphoid Cells in Airway Inflammation.
    Asghar Pasha M; Yang Q
    Adv Exp Med Biol; 2021; 1303():183-191. PubMed ID: 33788194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation.
    Mindt BC; Krisna SS; Duerr CU; Mancini M; Richer L; Vidal SM; Gerondakis S; Langlais D; Fritz JH
    Front Immunol; 2021; 12():664218. PubMed ID: 34867937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine and Lipid Mediator Regulation of Group 2 Innate Lymphoid Cells (ILC2s) in Human Allergic Airway Disease.
    Cavagnero K; Doherty TA
    J Cytokine Biol; 2017 Aug; 2(2):. PubMed ID: 28959799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T cells and type 2 innate lymphoid cell-dependent asthma.
    Aron JL; Akbari O
    Allergy; 2017 Aug; 72(8):1148-1155. PubMed ID: 28160290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid.
    Morita H; Kubo T; Rückert B; Ravindran A; Soyka MB; Rinaldi AO; Sugita K; Wawrzyniak M; Wawrzyniak P; Motomura K; Tamari M; Orimo K; Okada N; Arae K; Saito K; Altunbulakli C; Castro-Giner F; Tan G; Neumann A; Sudo K; O'Mahony L; Honda K; Nakae S; Saito H; Mjösberg J; Nilsson G; Matsumoto K; Akdis M; Akdis CA
    J Allergy Clin Immunol; 2019 Jun; 143(6):2190-2201.e9. PubMed ID: 30682454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 innate lymphoid cells: at the cross-roads in allergic asthma.
    van Rijt L; von Richthofen H; van Ree R
    Semin Immunopathol; 2016 Jul; 38(4):483-96. PubMed ID: 26965110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into Group 2 Innate Lymphoid Cells in Human Airway Disease.
    Karta MR; Broide DH; Doherty TA
    Curr Allergy Asthma Rep; 2016 Jan; 16(1):8. PubMed ID: 26746844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of type 2 innate lymphoid cell-dependent airway hyperreactivity by butyrate.
    Thio CL; Chi PY; Lai AC; Chang YJ
    J Allergy Clin Immunol; 2018 Dec; 142(6):1867-1883.e12. PubMed ID: 29522844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotriene C4 Potentiates IL-33-Induced Group 2 Innate Lymphoid Cell Activation and Lung Inflammation.
    Lund SJ; Portillo A; Cavagnero K; Baum RE; Naji LH; Badrani JH; Mehta A; Croft M; Broide DH; Doherty TA
    J Immunol; 2017 Aug; 199(3):1096-1104. PubMed ID: 28667163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are ILC2s Jekyll and Hyde in airway inflammation?
    Ealey KN; Moro K; Koyasu S
    Immunol Rev; 2017 Jul; 278(1):207-218. PubMed ID: 28658554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteinyl leukotriene E
    Salimi M; Stöger L; Liu W; Go S; Pavord I; Klenerman P; Ogg G; Xue L
    J Allergy Clin Immunol; 2017 Oct; 140(4):1090-1100.e11. PubMed ID: 28115217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps.
    Ogasawara N; Poposki JA; Klingler AI; Tan BK; Hulse KE; Stevens WW; Peters AT; Grammer LC; Welch KC; Smith SS; Conley DB; Raviv JR; Soroosh P; Takano KI; Himi T; Kern RC; Schleimer RP; Kato A
    Mucosal Immunol; 2020 Jan; 13(1):86-95. PubMed ID: 31641233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of group 2 innate lymphoid cells (ILC2) in respiratory allergic diseases: An update].
    Luo C; Liu S; Ren Q; Peng S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jun; 39(6):552-557. PubMed ID: 37340924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction.
    Rigas D; Lewis G; Aron JL; Wang B; Banie H; Sankaranarayanan I; Galle-Treger L; Maazi H; Lo R; Freeman GJ; Sharpe AH; Soroosh P; Akbari O
    J Allergy Clin Immunol; 2017 May; 139(5):1468-1477.e2. PubMed ID: 27717665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group 2 innate lymphoid cells in nasal polyposis.
    Stevens WW; Kato A
    Ann Allergy Asthma Immunol; 2021 Feb; 126(2):110-117. PubMed ID: 32781240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal-Activated ILC2s Promote IL-17A Production in Lung γδ T Cells During Sepsis.
    Chen W; Lai D; Li Y; Wang X; Pan Y; Fang X; Fan J; Shu Q
    Front Immunol; 2021; 12():670676. PubMed ID: 33995408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating ILC2 function for treatment of type 2 airway diseases.
    Huang YA; Strohm A; Doherty T
    Curr Trends Immunol; 2022; 23():85-90. PubMed ID: 37396395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.